Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates

Human leishmaniasis vaccines: Use cases, target population and potential global demand

(2021) Stefano Malvolti et al.   PLoS Neglected Tropical Diseases

Producing Standardized Country-Level Immunization Delivery Unit Cost Estimates

(2020) Allison Portnoy et al.   PHARMACOECONOMICS

Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019

(2020) Haidong Wang et al.   LANCET

Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates

(2019) Freddie Bailey et al.   PLoS Neglected Tropical Diseases

“Running the Gauntlet”: Formidable challenges in advancing neglected tropical diseases vaccines from development through licensure, and a “Call to Action”

(2019) Maria Elena Bottazzi et al.   Human Vaccines & Immunotherapeutics

“Cheaper and better”: Societal cost savings and budget impact of changing from systemic to intralesional pentavalent antimonials as the first-line treatment for cutaneous leishmaniasis in Bolivia

(2019) Daniel Eid Rodríguez et al.   PLoS Neglected Tropical Diseases

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study

(2019) Frédéric Debellut et al.   Lancet Global Health

Cost of visceral leishmaniasis care in Brazil

(2017) Isis Polianna Silva Ferreira de Carvalho et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

The yin and yang of leishmaniasis control

(2017) Shaden Kamhawi   PLoS Neglected Tropical Diseases

A new perspective on cutaneous leishmaniasis—Implications for global prevalence and burden of disease estimates

(2017) Freddie Bailey et al.   PLoS Neglected Tropical Diseases

Status of vaccine research and development of vaccines for leishmaniasis

(2016) Portia M. Gillespie et al.   VACCINE

Worldwide risk factors in leishmaniasis

(2016) A. Oryan et al.   Asian Pacific Journal of Tropical Medicine

Point-of-Care Viral Load Testing for Sub-Saharan Africa: Informing a Target Product Profile

(2016) Andrew N. Phillips et al.   Open Forum Infectious Diseases

Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries

(2015) Valentina Cambiano et al.   JOURNAL OF INFECTIOUS DISEASES

Post kala-azar dermal leishmaniasis: an unresolved mystery

(2014) Debanjan Mukhopadhyay et al.   TRENDS IN PARASITOLOGY

The Economic Value of a Visceral Leishmaniasis Vaccine in Bihar State, India

(2012) Bruce Y. Lee et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Leishmaniasis Worldwide and Global Estimates of Its Incidence

(2012) Jorge Alvar et al.   PLoS One

Low castes have poor access to visceral leishmaniasis treatment in Bihar, India

(2012) F. Pascual Martínez et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Leishmaniasis impact and treatment access

(2011) M. den Boer et al.   CLINICAL MICROBIOLOGY AND INFECTION

Estimation of Under-Reporting of Visceral Leishmaniasis Cases in Bihar, India

(2010) Vijay P. Singh et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Complexities of Assessing the Disease Burden Attributable to Leishmaniasis

(2008) Caryn Bern et al.   PLoS Neglected Tropical Diseases